NATERA, INC. Provision for Loan, Lease, and Other Losses
NATERA, INC. (NTRA) reported Provision for Loan, Lease, and Other Losses of $1.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForLoanLeaseAndOtherLosses · last filed 2026-08-07
- NATERA, INC. provision for loan, lease, and other losses for the quarter ending 2026-06-30 was $1.35M.
- NATERA, INC. provision for loan, lease, and other losses for the quarter ending 2026-03-31 was -$222.00K.
- NATERA, INC. provision for loan, lease, and other losses for the quarter ending 2025-09-30 was -$626.00K, a 216.79% decline year-over-year.
- NATERA, INC. provision for loan, lease, and other losses for the quarter ending 2025-06-30 was -$411.00K, a 322.16% decline year-over-year.
- NATERA, INC. provision for loan, lease, and other losses for fiscal 2021 was $156.00K.
| Period end | Provision for Loan, Lease, and Other Losses 3 month | Provision for Loan, Lease, and Other Losses 6 month | Provision for Loan, Lease, and Other Losses 9 month | Provision for Loan, Lease, and Other Losses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.35M 10-Q · filed 2026-08-07 | $1.13M 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | -$222.00K 10-Q · filed 2026-05-08 | |||
| 2025-09-30 | -$626.00K 10-Q · filed 2025-11-07 | -$1.04M derived: sum of 2 quarters · filed 2026-08-07 | -$1.23M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | -$411.00K 10-Q · filed 2026-08-07 | -$606.00K 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | -$195.00K 10-Q · filed 2026-05-08 | |||
| 2024-09-30 | $536.00K 10-Q · filed 2025-11-07 | $721.00K derived: sum of 2 quarters · filed 2025-11-07 | -$208.00K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $185.00K 10-Q · filed 2025-08-08 | -$744.00K 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | -$929.00K 10-Q · filed 2025-05-09 | |||
| 2023-09-30 | -$454.00K 10-Q · filed 2024-11-12 | -$900.00K derived: sum of 2 quarters · filed 2024-11-12 | -$2.20M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$446.00K 10-Q · filed 2024-08-09 | -$1.75M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | -$1.30M 10-Q · filed 2024-05-10 | |||
| 2022-09-30 | -$1.11M 10-Q · filed 2023-11-09 | -$2.29M derived: sum of 2 quarters · filed 2023-11-09 | -$2.62M 10-Q · filed 2023-11-09 | -$2.08M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$1.17M 10-Q · filed 2023-08-04 | -$1.50M 10-Q · filed 2023-08-04 | -$965.00K derived: sum of 3 quarters · filed 2023-08-04 | -$1.28M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | -$331.00K 10-Q · filed 2023-05-10 | $205.00K derived: sum of 2 quarters · filed 2023-05-10 | -$112.00K derived: sum of 3 quarters · filed 2023-05-10 | -$175.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $219.00K derived: sum of 2 quarters · filed 2022-11-09 | $156.00K derived: sum of 3 quarters · filed 2022-11-09 | $156.00K 10-K · filed 2022-02-25 |
| 2021-09-30 | -$317.00K 10-Q · filed 2022-11-09 | -$380.00K derived: sum of 2 quarters · filed 2022-11-09 | -$380.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$63.00K 10-Q · filed 2022-08-05 | -$63.00K 10-Q · filed 2022-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |